FISHER ANDREW (General Counsel) sold 18.2% of their position (80K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $922.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2025ACC: 0001104659-25-060652
Officer· General Counsel
Since Mar 2024
-80K
Net shares
Net seller
$922.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
80K acquired · 160K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+80K
Price / share
$2.01
Trade value
$160.90K
% of position
22.2%
6/16/2025
360K→440K
Ordinary Shares
Direct
Shares
−80K
Price / share
$11.53
Trade value
$922K
% of position
18.2%
6/16/2025
440K→360K
Total
Net shares
+0.00
Net value
-$761.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/16/2025 | M · Option Exercise | +80K | $2.01 | $160.90K | 22.2% | 360K | 440K |
| Ordinary Shares Direct | 6/16/2025 | S · Sale | −80K | $11.53 | $922K | 18.2% | 440K | 360K |
| Total | +0.00 | -$761.10K | ||||||
Derivative Transactions1
Share Options (Right to Buy)
Direct
Converts to
Ordinary Shares
80K shares
Shares
−80K
Strike price
2.0113
Held after
2.24M
Exercisable
—
6/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Options (Right to Buy) Direct | Ordinary Shares80K shares | 6/16/2025 | M · Option Exercise | −80K | 2.0113 | — | 2.24M |